Form D · Biotechnology
BLOEM LIFE ENTERPRISE, INC.
Houston, TX · CIK 0001874574
Offering snapshot reported Oct 26, 2021 · SEC filing
- Reported sold
- $145M Offering amount: $145M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 13, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2021 | Initial | $145,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-418626
Source: Form D, filed Oct 26, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Victor J Cardenas | Director, Executive |
| Gerardo Cardenas | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17150 Butte Creek Rd Suite 100
Houston, TX, 77090
Houston, TX, 77090